Responsive image

Common name


3-chloro-5-(4-methylsulfonylphenyl)pyridine

IUPAC name


3-chloro-5-(4-methylsulfonylphenyl)pyridine

SMILES


c1(ccc(cc1)S(=O)(=O)C)c2cc(cnc2)Cl

Common name


3-chloro-5-(4-methylsulfonylphenyl)pyridine

IUPAC name


3-chloro-5-(4-methylsulfonylphenyl)pyridine

SMILES


c1(ccc(cc1)S(=O)(=O)C)c2cc(cnc2)Cl

INCHI


InChI=1S/C12H10ClNO2S/c1-17(15,16)12-4-2-9(3-5-12)10-6-11(13)8-14-7-10/h2-8H,1H3

FORMULA


C12H10ClNO2S

Responsive image

Common name


3-chloro-5-(4-methylsulfonylphenyl)pyridine

IUPAC name


3-chloro-5-(4-methylsulfonylphenyl)pyridine





Molecular weight


267.731

clogP


2.879

clogS


-4.412

Frequency


0.0003





HBond Acceptor


3

HBond Donor


0

Total Polar
Surface Area


47.03

Number of Rings


2

Rotatable Bond


2

Drug ID Common name Structure CAS Compound class Therapeutic area
FDBD01277 Etoricoxib Responsive image Musculo-Skeletal System; Antiinflammatory and Antirheumatic Products, Non-Steroids; Antiinflammatory and Antirheumatic Products; Coxibs; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP1A2 Inducers; Cytochrome P-450 CYP2C9 Inducers; Cytochrome P-450 CYP2C19 Inducers; CYP2D6 Inducers; CYP2D6 Inducers (strong); CYP2E1 Inhibitors; CYP2E1 Inducers; CYP2E1 Inducers (strong); CYP3A4 Inhibitors; For the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, chronic low back pain, acute pain and gout.
1 , 1
FRAGNAME PDBID SIMILIRITY XSCORE SMILE HAC
5bnj_ligand_2_1.mol2 5bnj 0.563107 -7.86 c1(ccc(cc1)c1cc(cnc1)Cl)c1c[n+]([nH]c1)C 19
1utr_ligand.mol2 1utr 0.52809 -8.73 c1(c(Cl)cc(c(Cl)c1)S(=O)(=O)C)c1c(Cl)cc(c(Cl)c1)S(=O)(=O)C 25
2cen_ligand_3_203.mol2 2cen 0.52439 -6.95 c1cc(cnc1)c1ccc(cc1)C[NH3+] 14
4u5l_ligand_2_0.mol2 4u5l 0.52439 -6.65 c1cc(ccc1c1cnccc1)C[NH3+] 14
4cpt_ligand_3_209.mol2 4cpt 0.52439 -6.60 [NH3+]Cc1ccc(c2cccnc2)cc1 14
4u5o_ligand_2_0.mol2 4u5o 0.52439 -6.57 c1(ccc(cc1)C[NH3+])c1cccnc1 14
1ec2_ligand_3_11.mol2 1ec2 0.518072 -6.96 c1(ccc(cc1)c1cccnc1)CO 14
1ec2_ligand_3_303.mol2 1ec2 0.518072 -6.92 c1(ccc(cc1)c1cccnc1)CO 14
2ohs_ligand_3_6.mol2 2ohs 0.511905 -7.18 [NH3+]Cc1cccc(c1)c1cnccc1 14
2ohr_ligand_3_3.mol2 2ohr 0.511905 -7.08 c1(cccnc1)c1cccc(c1)C[NH3+] 14
102 , 11